Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma

Condition:   Multiple Myeloma Interventions:   Drug: Daratumumab;   Drug: velcade;   Drug: Lenalidomide;   Drug: dexamethasone Sponsors:   European Myeloma Network;   Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials